Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Jun 25;36:101810. doi: 10.1016/j.tmaid.2020.101810

Traditional Chinese Herbal Medication for corona-virus 2019

Amir Hassan 1
PMCID: PMC7316457  PMID: 32593869

Dear Editor,

At the end of December-2019 in china Wuhan city a viral infection transmission started from person to person effecting human body with many infections named as corona-virus [1]. This viral infection spread very rapidly across the china and multiplied in number in a very short time and migrated to other country by person migration. The WHO (World Health Organization) director general declared on January 30, 2020 that corona virus outbreak, health safety and emergency are recommended under the international health regulations [2]. On February 2, 2020 the China NHC (National Health Commission) reported about 304 deaths in a total of 14,488 cases in china and from other country total 146 cases confirmed with death number 1. This viral diseases is still continues throughout the world and today so many country are effected from that so proper attention towards this are needed and is important to discover and design therapeutic agents for this infection either form natural or from synthetic source. High risk and isolation should be preferred social interaction hand shaking must be stop and proper attention should be given at first positive stage. There are still no such effective antiviral drug or any vaccines are available for the corona virus infection because any specific treatment and drug designing required a lot of time however traditional Chinese medication is might available in 2003 outbreak of contagious disease severe acute respiratory syndrome (SARS) [3].

In china government recommended the usage of herbal medicine against viral-pneumonia and depend on sign and symptoms of patients and full literature of herbs were noticed before employment and is not necessary that it might possess direct antiviral pathology and potential but if possess it would be might useful for doctor in selection during the outbreak of severe acute respiratory syndrome (SARS) researcher given to Chinese traditional herbal medicinal plants and finding a novel and targeted and anti-corona viral compounds [4]. Found that this virus possess a number of protein helpful in replication most of them are Spike, 3CLprot (3C Like Protease) and PLprot (Papain Like Protease) protein were mainly studied the PLprot help in virus polypeptide protein and enzyme deubiquitinating for host against virus and eliminating the Ub (Ubiquitin) system. According to Ref. [5] In severe acute respiratory syndrome the PLprot breaks the UB-Like Protein ISG15, while LYS58 can linked the Poly-Ub Chain and releases in product DiUbLys48 while [6] reported that 3CLprot is responsible as cysteine-protease in the life cycle of virus and the spike protein Of Corona viruses uses angiotensin converting enzyme-II for receptor and provides help in of virus to inside the cell. These types of protein are helpful towards the new targeted designing of drug discovery. The naturally isolated compounds small molecules were screen and direct inhibition potency of proteins in severe acute respiratory syndrome was noticed in corona-virus. According to recent study that corona virus of 2019 gene in sequences were very closed in protein with SARS and MERS a severe acute respiratory syndrome and Middle East respiratory syndrome corona-virus. So it might easy to utilized the Traditional Chinese Herbal Medication for viral-pneumonia treatment and help in 2019 anti-corona virus in the light of MERS corona and SARS corona and is important to screen out the compounds for patients effected with this pathogen and need to find out any alternate of corona virus 2019 in a very short time.

Now it's necessary to find out anti-corona virus via herbal medication for those patients who suffer from that. In traditional Chinese medicine thirteen compounds found potent against anti-corona viral activity about one twenty-five herbs possess 2–13 compounds and twenty-six recommended shown in [Table 1 ] based on pharmacology for treating viral-respiratory infection and immune inflammation and posses direct effect against corona virus (COVID-19). The traditional or conventional medicine called drugs from plant preferred and recommended by a number of people due to zero or less health related side effects and is very effective efficient these herbs possess antiviral potential such as treating CORONA-VIRUS 2019 (COVID-19) pneumonia a respiratory viral infection; consideration and further evaluation are very important.

Table 1.

The list of 26 Traditional Chinese Herbs containing antiviral compound and their usage.

Serial Number Herbal Plant Name No. of Antiviral Compound Contain Catalogue Course Timing
1 Lonicerae japonicae flos 2 Antipyretic detoxifying Full
2 Hoveniae dulcis semen 2 Antipyretic detoxifying Middle
3 Forsythiae fructus 3 Antipyretic detoxifying Full
4 Rhizoma fagopyri cymosi 2 Antipyretic detoxifying Early
5 Houttuyniae herba 2 Antipyretic detoxifying Middle
6 Farfarae flos 2 Antitussive antiasthmatics Full
7 Eriobotryae folium 3 Antitussive antiasthmatics Middle-Later
8 Mori cortex 3 Antitussive antiasthmatics Full
9 Ardisiae japonicae herba 2 Antitussive antiasthmatics Middle-Later
10 Ardisiae japonicae herba 2 Antitussive antiasthmatics Middle-Later
11 Lepidii semen descurainiae semen 3 Antitussive antiasthmatics Middle-Later
12 Ginkgo semen 2 Antitussive antiasthmatics Later
13 Radix bupleuri 2 Pungent cool diaphoretics Middle
14 Chrysanthemi flos 2 Pungent cool diaphoretics Full
15 Mori follum 2 Pungent cool diaphoretics Full
16 Tamaricis cacumen 3 Pungentwarm exterior Early
17 Erigeron breviscapus 2 Pungentwarm exterior Early
18 Coptidis rhizome 2 Heat-clearing and dampness Middle
19 Inulae flos 2 Phlegm resolving medicine Middle-Later
20 Peucedani radix 2 Phlegm-resolving medicine Full
21 Licorice 3 Qi-reinforcing Full
22 Hedysarum multijugum maxim 3 Qi-reinforcing Middle-Later
23 Euphorbiae helioscopiae herba 2 Diuretic dampness-excreting Middle-Later
24 Anemarrhenae rhizome 3 Fire-purging Later
25 Epimrdii herba 2 Yang-reinforcing Later
26 Fortunes bossfern rhizome 2 Warming interior Prevention

Funding statement

None.

Declaration of competing interest

The author has no conflict of interest.

Acknowledgment

Special thanks to Professor Himayat Ullah of Chemistry Department Government Post Graduate College Mardan 23200 KP Pakistan for mindmaps during the study.

References

  • 1.Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019- nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79 doi: 10.1016/j.meegid.2020.104212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization . 2020-01-30. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [2020-02-02] [Google Scholar]
  • 3.Chen Z., Nakamura T. Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS. Phytother Res. 2004;18(7):592–594. doi: 10.1002/ptr.1485. [DOI] [PubMed] [Google Scholar]
  • 4.Lai L., Han X., Chen H., Wei P., Huang C., Liu S. Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase. Curr Pharmaceut Des. 2006;12(35):4555–4564. doi: 10.2174/138161206779010396. [DOI] [PubMed] [Google Scholar]
  • 5.Bhoj V.G., Chen Z.J. Ubiquitylation in innate and adaptive immunity. Nature. 2009;458(7237):430–437. doi: 10.1038/nature07959. [DOI] [PubMed] [Google Scholar]
  • 6.Mukherjee P., Shah F., Desai P., Avery M. Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model. 2011;51(6):1376–1392. doi: 10.1021/ci1004916. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Travel Medicine and Infectious Disease are provided here courtesy of Elsevier

RESOURCES